miRs-210/-155, HIF-1α, HIF-2α, Nrf2, and TGF-β are highly expressed in the majority of advanced ccRCC tumors and cooperatively regulate the expression of biomarkers critical for the pathogenesis of ccRCC and potentially critical therapeutic targets. The gene discussed is NFE2L2; the disease is nonpapillary renal cell carcinoma.